Sruthi Ravindranathan

Author

University of Arkansas at Fayetteville ORCID

Also Known As

Ravindranathan, Sruthi, S Ravindranathan, S. Ravindranathan, Sruthi Ravindranathan

Publications

743

Citations

H-Index

Concepts

All Affiliations

University of Arkansas at Fayetteville Emory University North Carolina State University University of North Carolina at Chapel Hill University of Arkansas for Medical Sciences

About

Sruthi Ravindranathan is an author at University of Arkansas at Fayetteville specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	68
2	Engineering	1	1	143
3	Health Sciences	1	1	10
4	Biomedical Engineering	1	1	143
5	Cell Biology	1	1	10

Sruthi Ravindranathan

Publications

649

Citations

H-Index

Page 1

	Year	Citations
Controlling chitosan-based encapsulation for protein and vaccine delivery Bhanu Koppolu, Sean G. Smith, Sruthi Ravindranathan, Biomaterials VaccinationNanomedicineEngineeringVaccine DeliveryMicro-encapsulation	2014	143
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity Christopher Ronald Funk, Shuhua Wang, Kevin Z. Chen, Blood	2022	115
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines Sruthi Ravindranathan, Khue G. Nguyen, Samantha L. Kurtz, Breast Cancer Research	2018	74
Effect of Chitosan Properties on Immunoreactivity Sruthi Ravindranathan, Bhanu Koppolu, Sean G. Smith, Marine Drugs	2016	65
Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis Jimmy LN Vo, Lirong Yang, Samantha L. Kurtz, OncoImmunology	2014	47
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer Sean G. Smith, Bhanu Koppolu, Sruthi Ravindranathan, Cancer Immunology Immunotherapy Radiation OncologyTumor ImmunologyTumor-specific Systemic ImmunityMurine Bladder CancerGenitourinary Cancer	2015	46
Raman spectroscopy reveals phenotype switches in breast cancer metastasis Santosh Kumar Paidi, Joel Rodríguez Troncoso, Mason G. Harper, Theranostics	2022	36
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer Sean G. Smith, John L. Baltz, Bhanu Koppolu, OncoImmunology	2016	33
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, Nature Communications	2022	32
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells Narendiran Rajasekaran, Xiaoguang Wang, Sruthi Ravindranathan, Cancer Immunology Immunotherapy	2024	25

Page 1